Literature DB >> 10923647

Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients.

P Wintermeyer1, R Krüger, W Kuhn, T Müller, D Woitalla, D Berg, G Becker, E Leroy, M Polymeropoulos, K Berger, H Przuntek, L Schöls, J T Epplen, O Riess.   

Abstract

Recently, an Ile93Met substitution has been identified in the ubiquitin carboxy-terminal hydrolase L1 (UCHL1) gene in a single German PD family with autosomal dominant inheritance. To determine whether mutations in the UCHL1 gene are causative for Parkinson's disease (PD) a detailed mutation analysis was performed in a large sample of German sporadic and familial PD patients. We found no disease-causing mutation in the coding region of the UCHL1 gene. Direct sequencing revealed six intronic polymorphisms in the UCHL1 gene. Analysis of an S18Y polymorphism in exon 3 of the UCHL1 gene in sporadic PD patients and controls showed carriers of allele 2 (tyrosine) significantly less frequent in patients with a reduced risk of 0.57 (CI = 0.36-0.88; p = 0.012, p(c) = 0.047, chi2 = 6.31). Our study shows that sequence variations in the coding region of UCHL1 are a rare event. A protective effect of a certain UCHL1 variant in the pathogenesis of sporadic PD is suggested, underlining the relevance of UCHL1 in neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923647     DOI: 10.1097/00001756-200007140-00004

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  26 in total

1.  Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease.

Authors:  T Franck; R Krueger; D Woitalla; T Müller; S Engelender; O Riess
Journal:  J Neural Transm (Vienna)       Date:  2006-06-06       Impact factor: 3.575

2.  Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.

Authors:  Zhihua Liu; Robin K Meray; Tom N Grammatopoulos; Ross A Fredenburg; Mark R Cookson; Yichin Liu; Todd Logan; Peter T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

Review 3.  Genetics of Parkinson disease.

Authors:  Nathan Pankratz; Tatiana Foroud
Journal:  NeuroRx       Date:  2004-04

4.  The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.

Authors:  Silke Metzger; Peter Bauer; Juergen Tomiuk; Franco Laccone; Stefano Didonato; Cinzia Gellera; Paola Soliveri; Herwig W Lange; Helga Weirich-Schwaiger; Gregor K Wenning; Bela Melegh; Victoria Havasi; Lazlo Balikó; Stefan Wieczorek; Larissa Arning; Jacek Zaremba; Anna Sulek; Dorota Hoffman-Zacharska; A Nazli Basak; Nagehan Ersoy; Jana Zidovska; Vera Kebrdlova; Massimo Pandolfo; Pascale Ribaï; Ludovit Kadasi; Marta Kvasnicova; Bernhard H F Weber; Friedmar Kreuz; Matthias Dose; Manfred Stuhrmann; Olaf Riess
Journal:  Neurogenetics       Date:  2005-12-21       Impact factor: 2.660

Review 5.  The genetics of Parkinson's disease.

Authors:  Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

6.  Rare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant Pedigrees.

Authors:  Stephanie A Zlatic; Alysia Vrailas-Mortimer; Avanti Gokhale; Lucas J Carey; Elizabeth Scott; Reid Burch; Morgan M McCall; Samantha Rudin-Rush; John Bowen Davis; Cortnie Hartwig; Erica Werner; Lian Li; Michael Petris; Victor Faundez
Journal:  Cell Syst       Date:  2018-01-31       Impact factor: 10.304

Review 7.  Parkinson's disease: Exit toxins, enter genetics.

Authors:  Marie Westerlund; Barry Hoffer; Lars Olson
Journal:  Prog Neurobiol       Date:  2009-11-17       Impact factor: 11.685

Review 8.  Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis.

Authors:  Margaret Ragland; Carolyn Hutter; Cyrus Zabetian; Karen Edwards
Journal:  Am J Epidemiol       Date:  2009-10-28       Impact factor: 4.897

9.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

10.  Merging mouse transcriptome analyses with Parkinson's disease linkage studies.

Authors:  Daniel Gherbassi; Lavinia Bhatt; Sandrine Thuret; Horst H Simon
Journal:  DNA Res       Date:  2007-05-23       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.